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Introduction:  Endemic  measles  persists  in China,  despite  >95%  reported  coverage  of two  measles-
containing  vaccine  doses  and nationwide  campaign  that  vaccinated  more  than  100 million  children  in
2010.  We performed  a case–control  study  in six  Chinese  provinces  during  January  2012  through  June
2013  to identify  risk  factors  for measles  infection  among  children  aged  0–7  months.
Methods: Children  with  laboratory-conﬁrmed  measles  were  neighborhood  matched  with three  controls.
We interviewed  parents  of  case  and  control  infants  on  potential  risk  factors  for measles.  Adjusted  matched
odds  ratios  (mOR)  and  95% conﬁdence  intervals  (CIs)  were  calculated  by  multivariable  conditional  logistic
modeling.  We  calculated  attributable  fractions  for risk  factors  that  could  be  interpreted  as  causal.
Results:  Eight  hundred  thirty  cases  and  2303  controls  were  enrolled.  In multivariable  analysis,  male  sex
(mOR 1.6  [1.3,  2.0]),  age  5–7 months  (mOR  3.9  [3.0, 5.1]),  migration  between  counties  (mOR  2.3 [1.6,  3.4]),
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outpatient  hospital  visits  (mOR  9.4  [6.6,  13.3])  and  inpatient  hospitalization  (mOR  107.1 [48.8, 235.1])
were  signiﬁcant  risk  factors.  The  calculated  attributable  fractions  for hospital  visits  was  43.1%  (95% CI:
40.1,  47.5%)  adjusted  for age,  sex and  migration.
Conclusions:  Hospital  visitation  was  the  largest  risk  factor  for measles  infection  in  infants.  Improved
hospital  infection  control  practices  would  accelerate  measles  elimination  in  China.
©  2016  The  Authors.  Published  by  Elsevier  Ltd. This  is an  open  access  article  under  the CC  BY-NC-NDDOI of original article: http://dx.doi.org/10.1016/j.vaccine.2016.02.005.
 Disclaimers: The ﬁndings and conclusions in this report are those of the authors
nd do not necessarily represent the ofﬁcial position of the Centers for Disease
ontrol and Prevention. Use of trade names and commercial sources are for identiﬁ-
ation purposes only and does not imply endorsement by the Public Health Service
r  the US Department of Health and Human Services.
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1. Introduction
A safe and effective vaccine for measles has been available for
more than 50 years, successfully eliminating the disease in many
countries. However, an estimated 122,000 measles-related deaths
occurred worldwide in 2011 [1]. All six World Health Organization
(WHO) regions now have measles elimination goals, but none have
yet replicated the success of the WHO  Region of the Americas [1].
In 2012, the WHO  Western Paciﬁc Region recorded its lowest-ever
measles incidence (5.9 per million population) [2], and appeared to
g/licenses/by-nc-nd/4.0/).
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–34 (2016) 655 656036554ig. 1. Incidence of reported measles cases by year, and the evolution of measles
accine; SIAs, supplementary immunization activities; M,  months; Y, years.
e approaching elimination. A large part of this success was due to a
ramatic reduction in the incidence of measles in China, historically
he source of most measles cases in the region, and the primary
orldwide reservoir for the H1 measles genotype [3].
In line with the WHO  Western Paciﬁc Region goal of measles
limination by 2012, China in 2006 endorsed an action plan for
easles elimination [4]. This plan to rapidly close the immunity
ap in children was similar to the successful AMR  elimination
lan, including a 2-dose routine measles-containing vaccine (MCV)
chedule with >95% coverage and use of supplementary immu-
ization activities (SIAs) [5]. In China, a ﬁrst MCV  dose is now
iven at age 8 months and a second between 18 and 23 months
ith >95% reported coverage for both doses [6]. To close accu-
ulated immunity gap among children with many measles cases
eported, between 2004 and 2009, 27 of 31 mainland provinces
onducted unsynchronized province-wide SIAs targeting children
ged 8 months to 14 years [6,7]. In September 2010, China con-
ucted a synchronized nationwide SIA and vaccinated more than
00 million children aged 8 months to 14 years [8]. After a sta-
le measles incidence of 50–100 cases per million population from
994 to 2008, incidence decreased rapidly in 2011 to 7.4 (Fig. 1).
owever, endemic measles virus transmission was not interrupted
fter the campaign [9].
National measles surveillance in China has shown an increasing
roportion of cases in infants <8 months old, a remarkable decrease
n incidence and percentage of cases in children aged 8 months
o 14 years old, and an increase in the proportion of cases, but
ot overall incidence, in adults aged ≥15 years. Between 1993 and
013, the proportion of measles cases among those aged <8 months
ncreased from <5% [10] to 31% [11]. Among children aged 8 months
o 14 years, the proportion of cases decreased from 83% to 42%; and
dult measles cases increased from 12% to 27% [10,11]. Infants <8
onths old are not eligible for measles vaccination, unfortunately,
his age group has had the highest incidence of measles in China
ince 2005 [8,12–14]. In 2013, the median age of conﬁrmed measles
ase-patients in China decreased to 11 months, the lowest since
easles surveillance began [9].
The notably low measles incidence after the nationwide measlesIA in 2010 provided an opportunity to assess the impact and
imitations of a vaccination strategy targeting children in epidemi-
logical situations where infants younger than the recommended
ge for vaccination make up most measles case-patients [9]. Ase routine immunization schedule—China, 1951–2013. Abbreviation: MV,  measles
risk factors for measles likely differ by age group, we  conducted
a case–control study during 2012–2013, after the nationwide SIA,
to identify risk factors for measles infection among infants, chil-
dren, and adults, and to guide further measles elimination efforts
in China. In this paper, we report results for infants aged ≤7 months.
2. Methods
2.1. Study location and time
Since 1986, China’s 31 mainland provinces have been divided
into three groups according to economic and social develop-
ment: eastern, central, and western regions [6,15]. We  selected
six provinces for the study based on geographic groupings men-
tioned above, an incidence of measles during 2005–2010 of >40
cases per million population, sustained measles virus transmission
in 2011, and >50% of cases occurring in infants aged 0–7 months
and adults aged ≥15 years. On the basis of these criteria, Jiangsu,
Zhejiang, and Shandong were selected from the more developed
eastern region, and Henan, Gansu, and Yunnan from the less devel-
oped central and western regions (Fig. 2). These six provinces have
a total population of around 394.5 million, 29.6% of the total pop-
ulation of China in 2010 [16]. The study sought to investigate all
laboratory-conﬁrmed measles cases reported from these provinces
from January to December 2012. Because the number of reported
cases did not meet the estimated sample size requirement by the
end of 2012 (see below), we  extended the study for 6 more months
to cover the 2013 peak measles season.
2.2. Sample size
For sample size calculation and data analysis, we combined
cases from the central and western regions because of overall
similar demographics and measles epidemiology. We calculated
sample size separately for each of three age groups (infants, chil-
dren and adults, as deﬁned above). For infants, assuming a risk
factor prevalence in controls of 30%, 134 infant cases with three
matched neighborhood controls in each of the eastern and cen-
tral/western regions would provide a 90% power to detect an odds
ratio (OR) >2 with 95% conﬁdence [17,18]. To account for a possible
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on-participation rate of 10%, we sought to investigate 150 infant
ases per area.
.3. Case selection
A case-based measles surveillance system with laboratory sup-
ort has been in place in China since 2009 [19]. Once a suspected
easles case seeks health care, the healthcare provider is expected
o report the case within 24 h. Suspected measles cases are con-
rmed based on laboratory ﬁndings, an epidemiologic link, or
linical criteria. For this study, only case-patients conﬁrmed by
ositive IgM enzyme-linked immunosorbent assay (SERION ELISA
nti-measles virus IgM, Institut Virion\Serion GmbH) or isolation
f measles virus in a WHO  Global Measles and Rubella Laboratory
etwork accredited laboratory were enrolled. Case-patients were
xcluded if they received MCV  7–14 days before rash onset [20] or
eclined to participate in the study. Cases were enrolled in each
rovince until the calculated sample size was reached for each age
roup or through June 2013, whichever came ﬁrst.
.4. Control selection
We  enrolled three 0–7 month old neighborhood matched con-
rols for each 0–7 month case-patient. Controls were selected
tarting with the household closest to that of the case-patient. If
ore than one age eligible individual lived in the household, we
elected the one closest in age to the case-patient. Subsequent
ouseholds were visited until three eligible controls were found
nd enrolled. Potential controls were excluded if caregivers refused
onsent for study participation or if the control infants had a his-
ory of fever and rash in the previous 3 months, to ensure that they
ere unlikely to be undiagnosed measles cases. control study—China, 2012–2013.
2.5. Data collection
Trained investigators conducted in-house face-to-face inter-
views with parents of case-patients and controls using a standard
questionnaire. Variables collected included demographic charac-
teristics, hospital exposure, routine vaccination history, and any
reasons for non-vaccination if appropriate, health care service
utilization and access, and migration status. Receipt of routine
vaccines was determined by household-retained vaccination card,
clinic-based vaccination records, or parental recall if written vac-
cination records were unavailable. Migration status was deﬁned
by either a personal history of the child having at least one
previous residence outside of the current county of residence
or a family history of ever having migrated from a different
county, prefecture, or province to the current place of resi-
dence.
2.6. Data analysis
A summary description of demographic variables and risk fac-
tors of interest was completed for all cases and controls. Matched
odds ratios (mORs) and 95% conﬁdence intervals (CIs) for risk
factors were calculated via conditional logistic regression over-
all and by region. Adjusted matched odds ratios were obtained
from a multivariable conditional logistic model. Model build-
ing sequentially assessed each factor’s signiﬁcance adjusted for
other variables in the model, as well as effect modiﬁcation on
the primary variable of interest, hospital visits for reason other
than vaccination. Attributable fractions (AF) were calculated for
those exposure risk factors that could be interpreted as causal,
using the formula: AF = P[E|D] × (1 − (1/mOR)), where P[E|D] is
the observed prevalence of the exposure among cases. We used
bootstrapping to calculate a 95% CI for the AF by repeatedly
sampling with replacement n matched sets, where n is the total
n
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umber of matched sets available in the analysis [21]. The 2.5th
nd 97.5th percentiles of 500 estimated AFs deﬁne the 95%
I.
.7. Ethical considerations
We  obtained written informed consent from parents or
uardians of participating children. The study protocol was
eviewed and approved by both the Ethics Review Committee of
he WHO  Regional ofﬁce for Western Paciﬁc Region (Unique ID
umber: 2011.24.CHN.05.EPI), and the Ethical Review Commit-
ee of China Center for disease control and prevention (Unique ID
umber: 201117).
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From January 2012 through June 2013, the six study provinces
eported 30,249 suspected measles cases (32.3% of the national
able 1
emographic characteristics of measles cases and age-matched controls aged 0–7 month
Eastern region, N (%) Centra
Cases (n = 360) Controls (n = 1046) Cases 
Sex (male) 242 (67) 572 (55) 313 (6
Age  (months)
0 2 (1) 14 (1) 1 
1  1 (0) 59 (6) 6 
2  7 (2) 94 (9) 11 
3  12 (3) 122 (12) 32 
4  42 (12) 157 (15) 59 (1
5  69 (19) 189 (18) 82 (1
6  105 (29) 206 (20) 142 (3
7  122 (34) 205 (20) 137 (2
Age  group
0–4 months 64 (18) 446 (43) 109 (2
5–7  months 296 (82) 600 (57) 361 (7
Vaccination card (yes) 356 (99) 1036 (99) 460 (9
Received all eligible doses
(yes)
196 (58) 847 (85) 226 (5
Mothers education
≤Primary school 27 (8) 71 (7) 99 (2
Middle school 292 (82) 821 (79) 343 (7
≥College 36 (10) 150 (14) 22 
Fathers education
≤Primary school 19 (5) 37 (4) 81 (1
Middle school 280 (79) 820 (79) 360 (7
≥College 57 (16) 184 (18) 25 
Type  of house
Multistory building 191 (53) 550 (53) 172 (3
Single-story house 156 (43) 481 (46) 281 (6
Other  12 (3) 15 (1) 13 
Number of siblings
0 248 (69) 732 (70) 248 (5
1  96 (27) 274 (26) 170 (3
≥2  14 (4) 37 (4) 51 (1
Primary caretaker
Parents 322 (90) 897 (86) 433 (9
Other  36 (10) 147 (14) 35 
Change in residence in child
Yes 49 (14) 74 (7) 35 
History of family migration
From different province 75 (21) 173 (17) 12 
From  different prefecture 92 (26) 196 (19) 40 
From  different county 104 (29) 219 (21) 60 (1
Non-vaccination hospital
visit in last 8–21 days
(yes)
172 (48) 64 (6) 201 (4
Type  of visit
Outpatient: 8–21 days 98 (27) 53 (5) 78 (1
Inpatient: 8–21 days 74 (21) 11 (1) 123 (2
No  visit 185 (52) 973 (94) 264 (5
ote: Discrepancies between sum of cases or controls listed for a variable and the total n
ach  variable and therefore omitted from this table. Exception:  Data for “received all eligitotal), of which 5978 (19.8%) were eventually classiﬁed as measles.
Among these 5978 case-patients, 5876 (98.3%) were laboratory
conﬁrmed, 6 (0.1%) were epidemiologically conﬁrmed and 96 (1.6%)
were clinically compatible. Among the laboratory conﬁrmed cases,
1730 (29.4%) were in infants aged <8 months, 2164 (36.9%) were
children aged 8 months through 14 years, and 1982 (33.7%) were in
adults aged ≥15 years. The percentage of measles cases in infants
aged <8 months ranged from 22.5% in Gansu to 39.8% in Henan. Dur-
ing this period, six measles-related deaths were reported in the six
provinces; three of these deaths were in infants <8 months. Among
471 cases of all ages with genotype results, 439 (93.2%) were H1,
and 32 (6.8%) were D9 genotype (30 from Yunnan province and 2
from Shandong province).
In total, 830 (47%) case-patients aged <8 months were enrolled
–(2016) 655 65603in this study: 360 from the eastern region and 470 from cen-
tral/western region. Yunnan contributed the largest number of
case-patients (254), followed by Henan (182), Shandong (177), Zhe-
jiang (143), Jiangsu (40), and Gansu (34). Enrolled and non-enrolled
s stratiﬁed by geographic area—China, 2012–2013.
l/western region, N (%) Total, N (%)
(n = 470) Controls (n = 1257) Cases (n = 830) Controls (n = 2303)
7) 683 (54) 555 (67) 1255 (54)
(0) 26 (2) 3 (0) 40 (2)
(1) 99 (8) 7 (1) 158 (7)
(2) 132 (11) 18 (2) 226 (10)
(7) 179 (14) 44 (5) 301 (13)
3) 179 (14) 101 (12) 336 (15)
7) 201 (16) 151 (18) 390 (17)
0) 222 (18) 247 (30) 428 (19)
9) 219 (17) 259 (31) 424 (18)
3) 615 (49) 173 (21) 1061 (46)
7) 642 (51) 657 (79) 1242 (54)
8) 1218 (97) 816 (98) 2254 (98)
6) 909 (83) 422 (57) 1756 (84)
1) 245 (20) 126 (15) 316 (14)
4) 941 (75) 635 (78) 1762 (77)
(5) 65 (5) 58 (7) 215 (9)
7) 170 (14) 100 (12) 207 (9)
7) 1003 (80) 640 (78) 1823 (80)
(5) 76 (6) 82 (10) 260 (11)
7) 447 (36) 363 (44) 997 (43)
0) 773 (62) 437 (53) 1254 (55)
(3) 31 (2) 25 (3) 46 (2)
3) 683 (54) 496 (60) 1415 (62)
6) 459 (37) 266 (32) 733 (32)
1) 114 (9) 65 (8) 151 (7)
3) 1151 (92) 755 (91) 2048 (89)
(7) 105 (8) 71 (9) 252 (11)
(8) 38 (3) 84 (10) 112 (5)
(3) 40 (3) 87 (11) 213 (9)
(9) 87 (7) 132 (16) 283 (12)
3) 126 (10) 164 (20) 345 (15)
3) 60 (5) 373 (45) 124 (5)
7) 50 (4) 176 (21) 103 (5)
6) 10 (1) 197 (24) 21 (1)
7) 1182 (95) 449 (55) 2155 (95)
umber of cases or controls reﬂect unknown or missing data, which were ≤2% for
ble doses” is missing in 11% of cases and 9% of controls.
Table  2
Characteristics associated with measles in children aged 0–7 months stratiﬁed by geographic area, matched case–control study—China, 2012–2013.
Variable description East Central/west Total
Number of
matched setsa
mOR (95% CI) Number of
matched sets
mOR  (95% CI) Number of
matched sets
mOR (95% CI)
Demographic variables
Sex (male:female) 360 1.7 (1.3, 2.3) 470 1.6 (1.3, 2.0) 830 1.7 (1.4, 2.0)
Age  group (5–7 months:0–4 months) 360 4.1 (3.0, 5.8) 470 3.6 (2.8, 4.7) 830 3.8 (3.1, 4.7)
Vaccination card (yes:no) 360 0.8 (0.2, 2.6) 469 1.6 (0.7, 3.7) 829 1.3 (0.6, 2.6)
Received all eligible doses (no:yes) 335 4.3 (3.2, 5.9) 387 4.9 (3.6, 6.7) 722 4.6 (3.7, 5.7)
Mother’s education 355 464 819
≤Primary:college+ 2.0 (1.0, 4.0) 1.4 (0.7, 2.6) 1.7 (1.1, 2.7)
Middle:college+ 1.8 (1.1, 2.9) 1.2 (0.7, 2.2) 1.6 (1.1, 2.3)
Father’s education 356 465 821
≤Primary:college+ 2.0 (0.9, 4.2) 1.7 (0.9, 3.1) 1.7 (1.1, 2.7)
Middle:college+ 1.2 (0.8, 1.8) 1.2 (0.7, 2.1) 1.2 (0.9, 1.7)
Type  of house 359 465 824
Multistory:single story 1.5 (0.9, 2.4) 1.0 (0.7, 1.5) 1.1 (0.8, 1.5)
Other:single story 9.7 (2.4, 38.4) 1.0 (0.4, 2.4) 2.0 (1.0, 4.0)
Any  siblings (yes:no) 358 1.0 (0.8, 1.4) 469 1.1 (0.9, 1.4) 827 1.1 (0.9, 1.3)
Care  taker (parents:other) 358 1.6 (1.0, 2.4) 468 1.1 (0.7, 1.7) 826 1.3 (1.0, 1.8)
Migration history
History of migration in child (yes:no) 360 2.5 (1.6, 4.0) 463 3.5 (2.0, 6.1) 823 2.9 (2.0, 4.1)
Family  migration between provinces (yes:no) 359 1.9 (1.2, 3.0) 469 0.7 (0.3, 1.4) 828 1.4 (0.9, 2.0)
Family  migration between prefectures (yes:no) 359 2.3 (1.5, 3.5) 469 1.3 (0.8, 2.2) 828 1.8 (1.3, 2.6)
Family  migration between counties (yes:no) 359 2.5 (1.6, 3.8) 469 1.5 (0.9, 2.4) 828 2.0 (1.5, 2.7)
Hospital exposure (non-vaccination visit)
Hospital visit in last 8–21 days (yes:no) 57 16.6 (10.9, 25.1) 465 21.3 (13.8, 32.8) 822 18.8 (13.9, 25.3)
Type  of visit in last 8–21 days
Outpatient visit: no Visit 357 10.7 (6.8, 16.8) 465 8.6 (5.4, 13.9) 822 9.7 (6.9, 13.4)
Inpatient visit: no visit 357 52.8 (20.9, 134) 465 20 7 (50.7, 848) 822 97.7 (45.4, 210)
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a Matched sets is the number of cases with at least one matched control.
ase-patients did not signiﬁcantly differ by age group (2 = 0.008,
 = 0.93) or sex (2 = 0.21, p = 0.65). The number of case-patients
ncreased progressively with age from three in the <1-month-old
ge-group to 259 in the 7-month-old age-group; 79% of cases were
n 5–7 month old children (Table 1). Among all potential control
nfants approached, 2520 controls were enrolled, 25 refused con-
ent for participation, and two were excluded for a history of fever
nd rash in the past 3 months. After enrollment, 217 (8.5%) con-
rol infants were excluded from analysis because they were aged
8 months; therefore, 2303 controls were included in the analysis.
Case-patients were more frequently male and older (median
ge: 6 months, IQR: 5–7 months) than controls (median age: 5
onths, IQR: 3–6 months) (Table 1). The sex distribution and
edian age of case-patients was similar between the eastern and
entral/western regions. Although ≥97% of case-patients and con-
rols in both regions reported possession of a vaccination card,
ases were less frequently up-to-date with all recommended vac-
ines (57% vs. 84%). Case-patients and controls has similar rates
f visit to a hospital or clinic for any reason at least once in the
–21 days before rash onset or interview, 58% and 46%, respec-
ively (data not shown). However, 45% of case-patients compared
ith only 5% of controls reported at least one visit to a hospital
r clinic for a reason other than vaccination 8–21 days before rash
nset or date of interview (Table 1). Reason for visits included fever
nd cough (37% case-patients; 3% controls), other illness (10% case-
atients, 2% controls) and other non-illness visits (4% case-patients,
% controls). Visits were further classiﬁed as inpatient (24% case-
atients, 1% controls) and non-inpatient (21% case-patients, 5%
ontrols). Case-patients and controls in the eastern region more
requently reported a history of changing residence or family
igration (county, prefecture, and province), parental education
eyond primary school, having one or no siblings, and residencein a multistory building than case-patients and controls from the
central/western regions (Table 1).
From univariate conditional logistic models, case-patients were
more likely than controls to have visited the hospital for a rea-
son other than vaccination in the 8–21 days before rash onset or
investigation date. This was true for all case-patients as well when
stratiﬁed by eastern and central/western regions (Table 2). Both
inpatient hospitalization and outpatient hospital visits were sig-
niﬁcantly associated with being a case-patient overall and in each
region. A personal history of changing residences was associated
with being a case-patient in both regions. Additional risk factors
for both regions included male sex, age 5–7 months, and missing
vaccine doses for other antigens (Table 2). In multivariable analysis,
male sex (mOR 1.6 [1.3, 2.0]), age 5–7 months (mOR 3.9 [3.0, 5.1]),
migration between counties (mOR 2.3 [1.6, 3.4]), outpatient hospi-
tal visits (mOR 9.4 [6.6, 13.3]) and inpatient hospitalization (mOR
107.1 [48.8, 235.1]) remained signiﬁcant risk factors. The calculated
attributable fractions of measles cases for any non-vaccine hospital
visit was  43.1% (95% CI: 40.1, 47.5) adjusted for age, sex and migrat-
ing from a different county. The AF for inpatient visits was 23.8%
(95% CI: 21.0, 27.4) and for outpatient was 19.2% (95% CI: 16.6, 22.8).
We calculated vaccination coverage among age eligible sub-
sets for each dose of HBV, DPT, and OPV. Ignoring the matched
design, the ﬁrst dose vaccination coverage was similar between
case-patients and controls; however coverage was lower for sec-
ond and third dose coverage among case-patients for all antigens
(Table 3). 1813 missed vaccinations doses among cases and con-
trols, 1660 (91.6%) caregivers reported a reason for the missed dose.
Most commonly, parents incorrectly believed that the child was too
young for vaccination or reported contraindication to vaccination;
together, these causes were responsible for 56–66% of all missed
vaccination opportunities.
 Table 3
Routine immunization coverage of HBV, DTP, OPV among children aged 0–7 months, matched case–control study—China, 2012–2013.
Vaccine dosage Age range for dose
eligible (months)
Eastern region number
(% vaccinated)
Central/west region
number (% vaccinated)
Total number (%
vaccinated)
Case Control Case Control Case Control
HBV1 1–7 350 (99) 1030 (100) 455 (98) 1213 (99) 805 (98) 2243 (99)
HBV2  2–7 345 (98) 959 (99) 431 (96) 1085 (98) 776 (97) 2044 (98)
HBV3  7 68 (61) 178 (88) 65 (56) 156 (85) 133 (59) 334 (86)
DTP1  4–7 306 (92) 731 (98) 355 (89) 754 (97) 661 (91) 1485 (97)
DTP2  5–7 237 (83) 560 (94) 263 (81) 544 (92) 500 (82) 1104 (93)
DTP3  6–7 141 (66) 320 (81) 156 (65) 314 (80) 297 (66) 634 (80)
OPV1  3–7 323 (94) 848 (97) 413 (95) 933 (97) 736 (95) 1781 (97)
OPV2  4–7 294 (89) 707 (95) 339 (87) 730 (95) 633 (88) 1437 (95)
526 (9
A  OPV, 
4
m
a
t
p
m
d
<
a
c
f
h
d
n
e
t
[
o
r
i
[
t
m
d
i
[
w
o
s
a
t
t
s
o
i
e
H
o
u
i
w
v
s
o
i
C. Ma  et al. / Vaccine –34 (2016) 655 656036558OPV3  5–7 219 (77) 
bbreviations:  HBV, hepatitis B vaccine; DTP, diphtheria-tetanus-pertussis vaccine;
. Discussion
In our study, hospital exposure was the primary risk factor for
easles infection in infants under vaccination age. The combined
ttributable fraction of 43% for inpatient and outpatient hospi-
al visits suggests that up to two in every ﬁve measles cases in
re-vaccination age children in China could be caused by nosoco-
ial exposure. Recent careful outbreak investigations in China have
emonstrated hospital exposure in up to 58% of case-patients aged
1 year [22] and have documented infusion rooms, inpatient wards,
nd waiting areas [22–25], as likely sites of disease acquisition, efﬁ-
ient locations for measles transmission as they are enclosed and
requently crowded [26–28].
A recent review of nosocomial measles transmission worldwide
ighlighted increasing reports of hospital transmission in the past
ecade, especially among young adults and infants in countries
earing measles elimination [29]. Several factors make measles
asily transmissible in hospital settings. Measles is extremely con-
agious with reported basic reproductive numbers from 6.2 to 15
30], and is most transmissible in the early stage. Before the onset
f rash, measles is not easily distinguished from other febrile respi-
atory illnesses. The respiratory symptoms facilitate production of
nfectious droplets, which can remain aerosolized for several hours
31,32]. As measles incidence falls, clinicians are less familiar with
he disease manifestations and diagnosis is frequently delayed or
issed altogether. Studies of hospitalized measles patients have
ocumented correct initial diagnosis rates of <20% [33], and prompt
nitiation of airborne isolation in <10% during the contagious phase
34]. Strict adherence to appropriate precautions for all patients
ith respiratory symptoms would not only decrease the likelihood
f measles transmission but also reduce the risk for nosocomial
pread of tuberculosis, inﬂuenza, and other pathogens spread via
irborne route. A recent study in Inner Mongolia demonstrated
hat 68% of healthcare workers (HCWs) were positive for latent
uberculosis, among the highest reported prevalence worldwide,
uggesting widespread nosocomial transmission [35]. Studies from
ther countries have documented that HCWs have an up to 19-fold
ncreased risk for acquiring measles when compared with the gen-
ral public [36,37]. Because they might transmit disease to patients,
CWs should either have documented protection against measles
r be vaccinated before starting work. Hospitals should maintain
p-to-date records of the protection status of all HCWs at their facil-
ties in a readily accessible and searchable format [29]. These steps
ould help reduce the risk for nosocomial outbreaks and protect
ulnerable populations such as infants from measles infection.
In line with the national surveillance data [11], cases in our
tudy most frequently occurred in children aged 5–7 months. We
bserved very few cases in 0–2 month-old infants and cases steadily
ncreased with age, consistent with the youngest infants being0) 230 (74) 503 (89) 449 (75) 1029 (89)
oral polio vaccine.
protected from infection by maternal antibodies. This correlates
with previous sero-epidemiological studies of measles antibod-
ies in China, which demonstrated decreasing seropositivity rates
from >70% in <1 month-old-infants to as low as 0–19% at 6
months [38–41]. As the majority of Chinese infants are suscep-
tible to measles before becoming eligible for MCV1 [42], these
infants must be protected by optimizing strategies to maintain
sufﬁcient herd immunity. Children should therefore receive the
ﬁrst dose of MCV  as soon as they are eligible. Since infants of
mothers with vaccine-induced immunity lose passive immunity
to measles approximately 3 months earlier than infants of moth-
ers with immunity acquired via measles disease [43], vaccination
of infants as young as 6 months old can be considered in outbreak
settings when a large proportion of cases occur in children under
8 months of age or the attack rate for children <8 months is high
[43,44]. Because of lower vaccine efﬁcacy at this age, these children
should be re-vaccinated as soon as possible after age 8 months [44].
Children who  were not up-to-date with other immunizations
were at increased risk for measles infection, despite not yet being
eligible for measles vaccination. This was true despite case-patients
and controls having generally similar demographics, apart from
case-patients being slightly older than controls. Why  children who
have not received other vaccines would be at risk for measles infec-
tion is unclear from our data, but it might suggest that there is a
subset of children who are both at increased risk of not receiving
timely vaccination and of being exposed to measles virus. These
children might have increased exposure to older children who have
not been vaccinated against measles or have increased exposure
to healthcare settings where they miss vaccination opportunities
and are at elevated risk for measles infection. For immunization
programs, this ﬁnding might present an opportunity to identify
early a cohort of children at increased risk for measles acquisition.
Defaulter tracking of children in immunization clinics could allow
this high-risk group to be targeted for close follow-up to ensure
that timely measles vaccination is accomplished. The most fre-
quent reason for missed vaccination was  lack of knowledge about
the appropriate age for vaccination. This suggests that increased
parental education on the importance of timely vaccination and
the recommended vaccination schedule is needed.
Our study has several limitations. The case-based measles
reporting system in the six provinces, like all surveillance sys-
tems, undoubtedly misses cases because of incomplete reporting
from community health systems—although the non-measles dis-
card rate is as high as 4 per 100,000 population, which may affect
the representativeness of included case-patients. Despite a delib-
erate attempt to select provinces with a range of demographic and
epidemiological characteristics, ﬁndings from this study might not
apply to all regions in China. However, the similarity of results
between study regions suggests nosocomial measles transmission
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ne 34s likely an important risk factor for measles among infants aged <8
onths in many areas of China. The exclusion of controls with fever
nd rash from the study could bias the study toward increasing the
ssociation between previous hospital exposure and measles infec-
ion, because these potential controls would presumably be more
ikely to have visited a hospital previously but would be excluded
rom our study. Available data indicate that exclusions due to fever
nd rash were few and would therefore be unlikely to signiﬁcantly
lter the strong association between hospital exposure and measles
nfection among infants. Parents of measles case-patients might be
ore likely to recall hospital visits because of heightened aware-
ess of events preceding the illness, but interviewers, carefully
rained before administering the interview, asked detailed standard
uestions to elicit hospital exposure history similarly for both case-
atients and controls. Neighboring matching of cases with controls,
tilized to reduce the risk of differential exposure to measles virus
iven the low level of recent disease transmission in China, limits
he ability to look at residence as a risk-factor for infection. This
lso likely lead to an underestimation of the association between
igration status and infection, as recent migrants in eastern China
end to predominately cluster in certain neighborhoods.
Protecting children too young for measles vaccination depends
n maintaining sufﬁcient herd immunity and insulating infants
rom possible exposure. Enhancing hospital infection control prac-
ices in China is necessary to decrease the risk for measles
ransmission among this vulnerable group. Additional educational
rograms for healthcare workers on infection control to raise
wareness of the risk for nosocomial disease transmission to both
atients and staff are required. Ill children should be physically
eparated as much as possible from well children in hospitals
o reduce the risk for exposure. Fever and rash cases should be
solated promptly, preferably in negative-pressure rooms if hospi-
alized, and hospitalization of suspected measles patients should
e limited to those with serious complications. Increased collabo-
ation between the immunization and infection control programs
t all levels in China is needed to implement measures to prevent
easles transmission in hospitals and accelerate progress toward
easles elimination in China.
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